{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:34:21Z","timestamp":1792427661266,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270910"],"award-info":[{"award-number":["82270910"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02281-3","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:17:06Z","timestamp":1776421026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Associations between cholesterol, high-density lipoprotein, and glucose index and hyperuricemia in patients with diabetes"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhihan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengzhe","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limeng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"2281_CR1","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout Lancet. 2021;397:1843\u201355.","journal-title":"Gout Lancet"},{"key":"2281_CR2","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/art.40807","volume":"71","author":"M Chen-Xu","year":"2019","unstructured":"Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK. Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007\u20132016. Arthritis Rheumatol. 2019;71:991\u20139.","journal-title":"Arthritis Rheumatol"},{"key":"2281_CR3","doi-asserted-by":"crossref","unstructured":"Liu R, et al. Prevalence of hyperuricemia and gout in Mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int. 2015;2015:762820.","DOI":"10.1155\/2015\/762820"},{"key":"2281_CR4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jare.2016.09.006","volume":"8","author":"K Hahn","year":"2017","unstructured":"Hahn K, Kanbay M, Lanaspa MA, Johnson RJ, Ejaz AA. Serum uric acid and acute kidney injury: A mini review. J Adv Res. 2017;8:529\u201336.","journal-title":"J Adv Res"},{"key":"2281_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12916-017-0890-9","volume":"15","author":"T Bardin","year":"2017","unstructured":"Bardin T, Richette P. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med. 2017;15:123.","journal-title":"BMC Med"},{"key":"2281_CR6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","volume":"9","author":"L Du","year":"2024","unstructured":"Du L, et al. Hyperuricemia and its related diseases: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9:212.","journal-title":"Signal Transduct Target Ther"},{"key":"2281_CR7","doi-asserted-by":"publisher","first-page":"102271","DOI":"10.1016\/j.redox.2022.102271","volume":"51","author":"WT Crawley","year":"2022","unstructured":"Crawley WT, Jungels CG, Stenmark KR, Fini MA. U-shaped association of uric acid to overall-cause mortality and its impact on clinical management of hyperuricemia. Redox Biol. 2022;51:102271.","journal-title":"Redox Biol"},{"key":"2281_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/dmrr.2768","volume":"32","author":"Y-H Chang","year":"2016","unstructured":"Chang Y-H, et al. Serum uric acid level as an indicator for CKD regression and progression in patients with type 2 diabetes mellitus-a 4.6-year cohort study. Diabetes Metab Res Rev. 2016;32:557\u201364.","journal-title":"Diabetes Metab Res Rev"},{"key":"2281_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s40618-013-0034-9","volume":"37","author":"J Zhang","year":"2014","unstructured":"Zhang J, Xiang G, Xiang L, Sun H. Serum uric acid is associated with arterial stiffness in men with newly diagnosed type 2 diabetes mellitus. J Endocrinol Invest. 2014;37:441\u20137.","journal-title":"J Endocrinol Invest"},{"key":"2281_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/jdi.14343","volume":"16","author":"A Mansoori","year":"2025","unstructured":"Mansoori A, et al. A novel index for diagnosis of type 2 diabetes mellitus: Cholesterol, High density lipoprotein, and Glucose (CHG) index. J Diabetes Investig. 2025;16:309\u201314.","journal-title":"J Diabetes Investig"},{"key":"2281_CR11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12933-025-02675-y","volume":"24","author":"D Mo","year":"2025","unstructured":"Mo D, Zhang P, Zhang M, Dai H, Guan J. Cholesterol, high-density lipoprotein, and glucose index versus triglyceride-glucose index in predicting cardiovascular disease risk: a cohort study. Cardiovasc Diabetol. 2025;24:116.","journal-title":"Cardiovasc Diabetol"},{"key":"2281_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1475-2840-10-72","volume":"10","author":"Q Li","year":"2011","unstructured":"Li Q, et al. Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol. 2011;10:72.","journal-title":"Cardiovasc Diabetol"},{"key":"2281_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12944-020-1197-y","volume":"19","author":"J Liang","year":"2020","unstructured":"Liang J, et al. The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study. Lipids Health Dis. 2020;19:31.","journal-title":"Lipids Health Dis"},{"key":"2281_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/annrheumdis-2014-205827","volume":"75","author":"YH Rho","year":"2016","unstructured":"Rho YH, et al. Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study. Ann Rheum Dis. 2016;75:91\u20135.","journal-title":"Ann Rheum Dis"},{"key":"2281_CR15","doi-asserted-by":"publisher","first-page":"25766","DOI":"10.1038\/srep25766","volume":"6","author":"A Pan","year":"2016","unstructured":"Pan A, Teng GG, Yuan J-M, Koh W-P. Bidirectional Association between Diabetes and Gout: the Singapore Chinese Health Study. Sci Rep. 2016;6:25766.","journal-title":"Sci Rep"},{"key":"2281_CR16","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.2337\/dc22-S002","volume":"45","author":"2","year":"2022","unstructured":"2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45:S17\u201338.","journal-title":"Diabetes Care"},{"key":"2281_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.hest.2025.10.003","volume":"6","author":"H Sun","year":"2025","unstructured":"Sun H, et al. Tongji Biobank: A High-Quality Repository Integrating Multi-Dimensional Biomedical Data. Brain Hemorrhages. 2025;6:315\u201322.","journal-title":"Brain Hemorrhages"},{"key":"2281_CR18","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig DI, Kang D-H, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811\u201321.","journal-title":"N Engl J Med"},{"key":"2281_CR19","unstructured":"Caterson ID, Inoue S, Zimmet PZ. The Asia-Pacific perspective: redefining obesity and its treatment. 2000. http:\/\/www.iotf.org\/asiapacific."},{"key":"2281_CR20","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.2337\/dc22-S006","volume":"45","author":"6","year":"2022","unstructured":"6. Glycemic Targets: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45:S83\u201396.","journal-title":"Diabetes Care"},{"key":"2281_CR21","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.2337\/dc22-S010","volume":"45","author":"10","year":"2022","unstructured":"10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45:S144\u201374.","journal-title":"Diabetes Care"},{"key":"2281_CR22","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1080\/07853890.2022.2118368","volume":"54","author":"Y Xu","year":"2022","unstructured":"Xu Y, et al. Association between dyslipidaemia and the risk of hyperuricaemia: a six-year longitudinal cohort study of elderly individuals in China. Ann Med. 2022;54:2402\u201310.","journal-title":"Ann Med"},{"key":"2281_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12902-023-01528-7","volume":"24","author":"Y Fang","year":"2024","unstructured":"Fang Y, et al. Dyslipidemia and hyperuricemia: a cross-sectional study of residents in Wuhu, China. BMC Endocr Disord. 2024;24:2.","journal-title":"BMC Endocr Disord"},{"key":"2281_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12944-021-01556-z","volume":"20","author":"Y Yu","year":"2021","unstructured":"Yu Y, et al. The association of lipid ratios with hyperuricemia in a rural Chinese hypertensive population. Lipids Health Dis. 2021;20:121.","journal-title":"Lipids Health Dis"},{"key":"2281_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12944-024-02171-4","volume":"23","author":"Z Wang","year":"2024","unstructured":"Wang Z, et al. The relationship between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and hyperuricaemia. Lipids Health Dis. 2024;23:187.","journal-title":"Lipids Health Dis"},{"key":"2281_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12944-024-02148-3","volume":"23","author":"H Lin","year":"2024","unstructured":"Lin H, Xu J, Teng C. Correlation between remnant cholesterol and hyperuricemia in patients with type 2 diabetes mellitus: a cross-sectional study. Lipids Health Dis. 2024;23:155.","journal-title":"Lipids Health Dis"},{"key":"2281_CR27","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/j.jacc.2008.03.016","volume":"51","author":"EM deGoma","year":"2008","unstructured":"deGoma EM, deGoma RL, Rader DJ. Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches. J Am Coll Cardiol. 2008;51:2199\u2013211.","journal-title":"J Am Coll Cardiol"},{"key":"2281_CR28","doi-asserted-by":"publisher","first-page":"1682279","DOI":"10.3389\/fendo.2025.1682279","volume":"16","author":"Y Cao","year":"2026","unstructured":"Cao Y, He Y, Zhu J, Han Y. Total cholesterol, high-density lipoprotein, and glucose (CHG) index and diabetic retinopathy in middle-aged and elderly Chinese adults with diabetes: a cross-sectional study. Front Endocrinol. 2026;16:1682279.","journal-title":"Front Endocrinol"},{"key":"2281_CR29","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/jdi.70086","volume":"16","author":"M \u00c7atak","year":"2025","unstructured":"\u00c7atak M, Konuk \u015eG, Hepsen S. The cholesterol-HDL-glucose (CHG) index and traditional adiposity markers in predicting diabetic retinopathy and nephropathy. J Diabetes Investig. 2025;16:1487\u201394.","journal-title":"J Diabetes Investig"},{"key":"2281_CR30","doi-asserted-by":"crossref","unstructured":"Zhang Y, et al. Associations of cumulative exposure and dynamic trajectories of cholesterol-HDL-glucose (CHG) index with cardiovascular disease in middle-aged and older Chinese adults: a longitudinal analysis. Cardiovasc Diabetol. 2026;25.","DOI":"10.1186\/s12933-026-03137-9"},{"key":"2281_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12933-026-03081-8","volume":"25","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, et al. Association of cumulative cholesterol-HDL-glucose index with blood pressure changes and risk of new-onset hypertension in middle-aged and older adults: a cohort study. Cardiovasc Diabetol. 2026;25:49.","journal-title":"Cardiovasc Diabetol"},{"key":"2281_CR32","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s40520-025-03243-w","volume":"37","author":"Q Xiao","year":"2025","unstructured":"Xiao Q, et al. Evaluating the role of CHG index in predicting stroke risk among adults with varying glucose regulation. Aging Clin Exp Res. 2025;37:334.","journal-title":"Aging Clin Exp Res"},{"key":"2281_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12933-025-02906-2","volume":"24","author":"Z Guo","year":"2025","unstructured":"Guo Z, et al. Association between cholesterol, high-density lipoprotein, and glucose index and risks of cardiovascular and all-cause mortality in patients with calcific aortic valve stenosis: the ARISTOTLE cohort study. Cardiovasc Diabetol. 2025;24:393.","journal-title":"Cardiovasc Diabetol"},{"key":"2281_CR34","doi-asserted-by":"crossref","unstructured":"Ruan H, Zhang Q, Zhang P, Tang Y, Ran X. Prognostic value of TC\/HDL-C ratios in ischemic stroke: a multicenter observational study. Brain Hemorrhages. 2026.","DOI":"10.1016\/j.hest.2026.01.003"},{"key":"2281_CR35","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1038\/s41440-025-02311-y","volume":"48","author":"T Takata","year":"2025","unstructured":"Takata T, Mae Y, Hoi S, Hisatome I, Isomoto H. Redefining hyperuricemia in chronic kidney disease: a focus on tubulo-glomerular urate handling. Hypertens Res. 2025;48:2766\u20137.","journal-title":"Hypertens Res"},{"key":"2281_CR36","doi-asserted-by":"crossref","unstructured":"Takata T, Mae Y, Hoi S, Iyama T, Isomoto H. Hyperuricemia in Chronic Kidney Disease: Emerging Pathophysiology and a Novel Therapeutic Strategy. Int J Mol Sci. 2025;26.","DOI":"10.3390\/ijms26189000"},{"key":"2281_CR37","doi-asserted-by":"crossref","unstructured":"Peng TC, et al. Relationship between hyperuricemia and lipid profiles in US adults. Biomed Res Int. 2015;127596.","DOI":"10.1155\/2015\/127596"},{"key":"2281_CR38","doi-asserted-by":"crossref","unstructured":"Yang WX, Ma Y, Hou YL, Wang YB, You CG. Prevalence of hyperuricemia and its correlation with serum lipids and blood glucose in physical examination population in 2015\u20132018: a Retrospective Study. Clin Lab. 2019;65.","DOI":"10.7754\/Clin.Lab.2019.190338"},{"key":"2281_CR39","doi-asserted-by":"publisher","first-page":"F826","DOI":"10.1152\/ajprenal.00012.2017","volume":"313","author":"D Toyoki","year":"2017","unstructured":"Toyoki D, et al. Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and ATP-binding cassette subfamily G member 2. Am J Physiol Ren Physiol. 2017;313:F826\u201334.","journal-title":"Am J Physiol Ren Physiol"},{"key":"2281_CR40","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00296-015-3242-0","volume":"35","author":"F Perez-Ruiz","year":"2015","unstructured":"Perez-Ruiz F, et al. Renal clearance of uric acid is linked to insulin resistance and lower excretion of sodium in gout patients. Rheumatol Int. 2015;35:1519\u201324.","journal-title":"Rheumatol Int"},{"key":"2281_CR41","doi-asserted-by":"crossref","unstructured":"Poznyak A, et al. The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci. 2020;21.","DOI":"10.3390\/ijms21051835"},{"key":"2281_CR42","doi-asserted-by":"crossref","unstructured":"He J, et al. Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism. Int J Mol Sci. 2020;21.","DOI":"10.3390\/ijms21176356"},{"key":"2281_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12902-022-00937-4","volume":"22","author":"Y Al Shanableh","year":"2022","unstructured":"Al Shanableh Y, et al. Prevalence of asymptomatic hyperuricemia and its association with prediabetes, dyslipidemia and subclinical inflammation markers among young healthy adults in Qatar. BMC Endocr Disord. 2022;22:21.","journal-title":"BMC Endocr Disord"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02281-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02281-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02281-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T01:12:38Z","timestamp":1780276358000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02281-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2281"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02281-3","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval from Tongji Hospital\u2019s Institutional Review Board. Given that our research involved only the retrospective analysis of a de-identified database, informed consent was exempted. The research has been performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}